Condition: Degenerative Spine Disease · Sponsor: DePuy Synthes Products, Inc.
This is a post-market, prospective, controlled, multicenter clinical study to evaluate radiographic fusion and clinical outcomes of FIBERGRAFT™ Aeridyan Matrix bone graft substitute in subjects who undergo a 1-3 level instrumented lumbar posterolateral fusion surgery. This clinical study will be conducted at up to 10 clinical sites within the United States.
This description comes directly from the study's public registry record.
Study Contact · 857-488-0221 · kcorrado@its.jnj.com
Kristin Corrado, B.S · kcorrado@its.jnj.com
Always discuss trial participation with your own doctor first.
| UC Davis Health System | Sacramento, California, United States | Recruiting |
| University Of Illinois | Chicago, Illinois, United States | Recruiting |
| University of Kentucky Medical Center | Lexington, Kentucky, United States | Recruiting |
| Brigham And Women's Hospital | Boston, Massachusetts, United States | Recruiting |
| Mayo Clinic Rochester | Rochester, Minnesota, United States | Not Yet Recruiting |
| Duke University Medical Center | Durham, North Carolina, United States | Not Yet Recruiting |
| Rothman Orthopaedics Institute | Philadelphia, Pennsylvania, United States | Recruiting |
| UT Health Houston | Houston, Texas, United States | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07059065